Meury William

Meury William serves as a Director at Incyte Corporation, a firm focused on innovative cancer therapies. His recent insider trading activity includes 7 public disclosures from February 7, 2025, to July 7, 2026, primarily involving Incyte Corporation (INCY) and Syndax Pharmaceuticals Inc (SNDX). The disclosed amounts range from $558.5K to a substantial $7.8M, with the largest move being a grant/exercise valued at $7.8M on June 30, 2025.